-The Hindu Well before the Supreme Court rejected Novartis' application for patent for Glivec (Gleevec in the U.S.), drawing attention to the dichotomy of generic and patented drugs, activists have been demanding access to expensive drugs used in the treatment of cancer, hepatitis C and serious HIV. Trastuzumab is one such, used in the treatment of HER2+ type of breast cancer, which affects about one in four patients with the disease. Rough...
More »SEARCH RESULT
Total Matching Records found : 150
'Delayed diagnosis a major challenge in TB control'-Aarti Dhar
-The Hindu India may have achieved a success rate of 88 per cent in treatment of tuberculosis - higher than the global treatment success rate of 85 per cent - but HIV-TB co-infection continues to be a cause of major concern, as the percentage of people infected with the twin infection increased substantially between 2010 and 2011. The percentage of TB patients tested for HIV increased nationally from 32 per cent...
More »No country for newborn children -Aarti Dhar
-The Hindu India accounts for the largest number of deaths of infants primarily because it has failed to provide them and their mothers access to critical health care India loses 4,200 children under the age of five every day. This figure is certainly unacceptable for any emerging country. The collective ache of losing so many newborns is worsened by the realisation that many of these deaths are preventable. The country accounts for nearly...
More »Was U.S. baby infected with HIV at all? -R Prasad
-The Hindu Chennai: A few days after the news broke of a “functional cure” in a HIV-positive Mississippian baby aged two-and-a-half, many questions have been raised whether the baby was indeed infected with HIV. “There are many instances where the mother’s HIV particles (HIV RNA) can be present in the newborn’s blood,” Dr. N. Kumarasamy told this correspondent from Atlanta, U.S. Dr. Kumarasamy is the Chief Medical Officer at YRGCARE, Chennai, and is...
More »Panel seeks warning labels on medicines -Durgesh Nandan Jha
-The Times of India All antibiotics, TB drugs and other habit-forming medicines may soon come with a label warning users about the dangers of taking them without medical advice. Recommending this to the health ministry as a way to address the problem of drug resistance, a task force has also suggested creating a new category, H1, for these drugs by amending the Drugs and Cosmetics Rules, 1945. Health minister Ghulam Nabi Azad...
More »
